CURRENT POSSIBILITIES OF USING RADIOPHARMACEUTICALS TO EVALUATE CEREBRAL BLOOD FLOW

CURRENT POSSIBILITIES OF USING RADIOPHARMACEUTICALS TO EVALUATE CEREBRAL BLOOD FLOW

A comparison of the possibilities of using various neurotropic radiopharmaceuticals for scintigraphic evaluation of cerebral perfusion. In the whole range of radiopharmaceuticals used to diagnose cerebral blood flow disorders, there are Ceretec (99mTc-hexamethylpropyleneamine) and Neurolite (N,N-1,2...

Full description

Bibliographic Details
Main Authors: N. Yu. N.Yu. Efimova, N. G. Krivonogov, Yu. B. Lishmanov, I. Yu. Efimova
Format: Article
Language:English
Published: LUCHEVAYA DIAGNOSTIKA, LLC 2017-03-01
Series:Вестник рентгенологии и радиологии
Subjects:
review
<sub>99m</sub>tc-hexamethylpropyleneamine
n,n-1,2-ethylenediylbis-l-cysteine-diethyl ether
cerebral perfusion
Online Access:https://www.russianradiology.ru/jour/article/view/196

Internet

https://www.russianradiology.ru/jour/article/view/196

Similar Items